ZORYVE ® (roflumilast) foam 0.3% is a once-daily, steroid-free, leave-in topical foam uniquely formulated to treat the itching, redness, and flaking of seborrheic dermatitis anywhere it appears, ...

Throughout the year, we saw robust net product sales revenue growth, steady prescription growth, and strong market share ...

Max Homa opens up about joining the Free to Be Me campaign, sharing his personal health journey and encouraging others to seek proper care.

It’s one thing for poor form to ruin your performance in a tournament. Every pro has those moments on the course where things ...

Arcutis Biotherapeutics delivered a strong Q4 2025, with $127.5M in revenue and a GAAP EPS beat, driven by Zoryve's rapid ...

Mandelic acid for the scalp gently exfoliates, reduces dandruff and oil, unclogs follicles, and supports healthier hair ...

Q4 2025 net product revenue for ZORYVE (roflumilast) was $127.5 million, an 84% increase compared to Q4 2024, and a 29% increase compared to Q3 2025Full year 2025 net product revenue for ZORYVE was ...

Russia’s punishing attacks on Ukraine’s power grid this winter haven’t deterred its resilient people, like these six women, from the beauty routines that make them feel “normal and grounded.” ...

Wall Street expects Arcutis to post earnings of 8 cents per share on revenue of $111.14 million, representing 55.88% year-over-year revenue growth. The forecast would mark sequential improvement from ...

Lightweight, non-greasy and deeply hydrating, shoppers say they use this jojoba oil for practically any skin, hair and nail ...

Give your itchy scalp some soothing relief this winter with these recommendations from dermatologist Elyse Love.

The six-time PGA Tour winner once suffered from seborrheic dermatitis, a chronic inflammatory disease that causes dandruff, ...